Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2408 clinical trials
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7) (HERMIONE-7)

The HERMIONE-7 trial is a phase II, single-arm, open-label, multicenter study in HR+, HER2- advanced breast cancer patients who have received HD-FUL as first-line endocrine treatment for their

progesterone
cish
progesterone receptor
abemaciclib
estrogen
  • 39 views
  • 25 Mar, 2022
  • 38 locations
Palbociclib Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer

This study is investigating the combination of palbociclib, letrozole and venetoclax in ER and BCL-2 positive locally advanced or metastatic breast cancer. It is hypothesised that

palbociclib
carcinoma
mirena
metastatic carcinoma
metastasis
  • 45 views
  • 24 Jan, 2021
  • 3 locations
  • 0 views
  • 19 Nov, 2021
  • 28 locations
Motivating to Exercise and Diet and Educating to Healthy Behaviors After Breast Cancer

The primary objective of MEDEA is to compare the effect of a personalised telephone-based health education weight loss program based on motivational coaching, exercise and diet versus a standard health educational program control on fatigue of overweight or obese BC patients (as measured by the EORTC QLQ C30 (Aaronson et …

  • 0 views
  • 06 Mar, 2021
  • 1 location
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer

This study will test the iBreastExam device to find out whether it can detect a mass or lump in the breast as accurately as a routine breast cancer screening examination. The iBreastExam

  • 0 views
  • 25 Mar, 2022
  • 2 locations
Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)

hypotheses that REMD-477 is safe and tolerable in patients with severe hyperglycemia on apelisib and prevent hyperglycemia associated with alpelisib in patients with advanced breast cancer who discontinue

  • 1 views
  • 25 Nov, 2021
  • 1 location
Neoadjuvant Endocrine Therapy Tolerance in Geriatric Early Stage ER+ Breast Cancer (POWER)

This single arm pilot study evaluates the use of pre-operative endocrine therapy in women with early stage ER+ breast cancer who are 65 years or older and are scheduled to have breast

letrozole
anastrozole
endocrine therapy
hormone therapy
aromatase inhibitor
  • 1 views
  • 23 Apr, 2022
  • 1 location
Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer (XenoBreast)

with that of the PDXs. It aims to develop xenografts from tumor samples from surgical specimens of patients with triple negative or luminal B breast cancer.

  • 0 views
  • 07 Apr, 2022
  • 1 location
The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

The management of HR-positive, HER2-negative metastatic breast cancer includes endocrine monotherapy or combination regimens, both with benefit diminishing as resistance develops. Nowadays

  • 0 views
  • 21 Oct, 2021
  • 1 location
A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer

Her2 negative recurrent/metastatic breast cancer and have received prior endocrine therapy are eligible for study.

  • 0 views
  • 23 Mar, 2022
  • 1 location